These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2319157)
1. Fatal visceral disease caused by a dermotropic Leishmania in a patient with human immunodeficiency virus infection. Gradoni L; Gramiccia M; Betti F J Infect; 1990 Mar; 20(2):180-2. PubMed ID: 2319157 [No Abstract] [Full Text] [Related]
2. [Visceral leishmaniasis with cardiac affectation in an immunocompetent patient]. Puerto-Alonso JL; Molina-Ruano FJ; Gómez-Soto F; Gómez-Rodríguez F Med Clin (Barc); 2006 Oct; 127(13):519. PubMed ID: 17043012 [No Abstract] [Full Text] [Related]
3. [Spontaneous rupture of the spleen in a patient with visceral leishmaniasis]. Rovira RE; Díaz-Gómez JR; Lapuebla X; Aguar MC Enferm Infecc Microbiol Clin; 2005 May; 23(5):327. PubMed ID: 15899186 [No Abstract] [Full Text] [Related]
4. Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis. Peces R; de la Torre M; Alcázar R Nephrol Dial Transplant; 1996 Apr; 11(4):707-8. PubMed ID: 8671866 [No Abstract] [Full Text] [Related]
5. Visceral leishmaniasis in a Brazilian child infected perinatally with human immunodeficiency virus. Ferreira E; Lucena S; Fonseca G; Barbosa TC; Aquino RB; Lambert JS; Nogueira SA Pediatr Infect Dis J; 2001 Feb; 20(2):224-6. PubMed ID: 11224850 [TBL] [Abstract][Full Text] [Related]
6. [Visceral leishmaniasis associated with human immunodeficiency virus infection]. Pintado V; López-Vélez R Enferm Infecc Microbiol Clin; 2001; 19(7):353-7. PubMed ID: 11747803 [No Abstract] [Full Text] [Related]
7. Visceral leishmaniasis in a patient with human immunodeficiency virus. Rizzi M; Arici C; Bonaccorso C; Gavazzeni G Trans R Soc Trop Med Hyg; 1988; 82(4):565. PubMed ID: 3256108 [No Abstract] [Full Text] [Related]
8. Visceral leishmaniasis with pericarditis in an HIV-infected patient. Mofredj A; Guerin JM; Leibinger F; Masmoudi R Scand J Infect Dis; 2002; 34(2):151-3. PubMed ID: 11928856 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Faraut-Gambarelli F; Piarroux R; Deniau M; Giusiano B; Marty P; Michel G; Faugère B; Dumon H Antimicrob Agents Chemother; 1997 Apr; 41(4):827-30. PubMed ID: 9087498 [TBL] [Abstract][Full Text] [Related]
10. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient. Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688 [TBL] [Abstract][Full Text] [Related]
11. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)]. Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998 [No Abstract] [Full Text] [Related]
12. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV. Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514 [TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS). Hernández DE; Oliver M; Martínez C; Planas G Int J Dermatol; 1995 Feb; 34(2):114-5. PubMed ID: 7737768 [No Abstract] [Full Text] [Related]
14. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. Delgado J; Macías J; Pineda JA; Corzo JE; González-Moreno MP; de la Rosa R; Sánchez-Quijano A; Leal M; Lissen E Am J Trop Med Hyg; 1999 Nov; 61(5):766-9. PubMed ID: 10586909 [TBL] [Abstract][Full Text] [Related]
15. [Circumscribed and confluent papular rash in the trunk and hands in a male patient infected with the human immunodeficiency virus]. Peña A; Moreno S; Ramos JM; Menasalvas AI; Nieto A; Blázquez RM Enferm Infecc Microbiol Clin; 2001; 19(7):339-40. PubMed ID: 11747792 [No Abstract] [Full Text] [Related]
16. Visceral leishmaniasis: a lingual presentation in a patient with HIV infection. Vázquez-Piñeiro T; Fernández Alvarez JM; Gonzalo Lafuente JC; Cano J; Gimeno M; Berenguer J Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Aug; 86(2):179-82. PubMed ID: 9720093 [TBL] [Abstract][Full Text] [Related]
17. A 7-month-old girl with fever and bleeding. Chaliasos N; Bourantas C; Kritikou E; Lapatsanis P Lancet; 1996 Apr; 347(9008):1086. PubMed ID: 8602061 [No Abstract] [Full Text] [Related]
18. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group. Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341 [TBL] [Abstract][Full Text] [Related]
20. Novel methods for the encapsulation of meglumine antimoniate into liposomes. Frézard F; Michalick MS; Soares CF; Demicheli C Braz J Med Biol Res; 2000 Jul; 33(7):841-6. PubMed ID: 10881061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]